サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1623048

医薬品ロジスティクスの世界市場規模：ロジスティクスタイプ別、処理別、用途別、地域別、範囲および予測

Global Pharmaceutical Logistics Market Size By Type of Logistics, By Procedure, By Application, By Geographic Scope And Forecast

出版日
ページ情報
英文 202 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.28円
医薬品ロジスティクスの世界市場規模：ロジスティクスタイプ別、処理別、用途別、地域別、範囲および予測
出版日: 2024年07月31日
発行: Verified Market Research
ページ情報: 英文 202 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

医薬品ロジスティクスの市場規模と予測

医薬品ロジスティクスの市場規模は、2024年に1,659億4,000万米ドルと評価され、2024年～2031年の間に12.61％のCAGRで成長する見込みで、2031年には4,291億1,000万米ドルに達すると予測されます。医薬品ロジスティクスは、ヘルスケアサプライチェーンの重要な一部であり、メーカーからエンドユーザーまでの医薬品の輸送、保管、流通を包括しています。この専門分野は、処方薬、一般用医薬品、ワクチン、生物製剤を含む医薬品が、安全かつ効率的に、厳格な規制基準に準拠して配送されることを保証します。これらの製品は繊細であるため、サプライチェーン全体で完全性、安全性、規制遵守を維持することが最も重要です。

医薬品ロジスティクスの重要な機能には、医薬品有効成分（API）や賦形剤など、医薬品製造のための原材料の輸送と保管が含まれます。これらの原材料の品質と有効性を維持するためには、効果的なロジスティクス管理が不可欠であり、特に温度に敏感な品目は温度管理が重要です。

さらに、個別化医療と生物製剤への注目の高まりは、医薬品ロジスティクスの将来に大きな影響を与えます。個別化医療は個々の患者の特性に合わせた治療を行うため、少量でカスタマイズされた医薬品の輸送が必要となります。

世界の医薬品ロジスティクス市場力学

主な市場促進要因

成長する医薬品産業と世界の医薬品販売：

製薬業界の拡大と世界の医薬品販売の増加は、効率的なロジスティクスソリューションの需要を促進しています。Verified Market Researchによると、医薬品製造装置市場の市場規模は2023年に139億5,000万米ドルと推定され、2031年には224億1,000万米ドルに達すると予測されています。

温度に敏感な医薬品とバイオ医薬品の増加：

温度に敏感な医薬品とバイオ医薬品の生産と流通の増加が、専門的なコールドチェーンロジスティクスの必要性を高めています。Verified Market Researchによると、バイオ医薬品市場規模は2023年に4,138億3,000万米ドルと評価され、2024年から2031年までのCAGRは6.30%で、2031年には6,746億6,000万米ドルに達すると予測されています。

医薬品分野におけるeコマースの成長：

eコマースの急速な成長は、eコマースのパンデミックによって加速され、効率的なラストワンマイルデリバリーや患者直送ロジスティクスソリューションの需要を促進しています。米国では、健康、パーソナルケア、美容製品のeコマース売上は2020年に32.4％成長し、721億米ドルに達した（米国国勢調査局、2021年）。

主な課題

厳しい規制要件：

医薬品ロジスティクス・プロバイダーは、製品の品質と安全性を維持するために厳しい規制を遵守しなければならないです。EUでは、年間約200件の適正流通規範（GDP）検査が実施されており、非遵守率は5％から15％となっています。

温度過昇と製品の腐敗：

サプライチェーン全体で適切な温度管理を維持することは極めて重要であるが課題であり、製品の腐敗や経済的損失の可能性があります。ワクチンの25％が誤った輸送手順のために劣化した状態で目的地に到着し、その損失は年間341億米ドルに上ると推定されている（世界保健機関、2020年）。

高い運営コストとインフラ要件：

医薬品ロジスティクス市場は、特殊な設備、保管施設、輸送に関連する高コストのために課題に直面しています。医薬品グレードの倉庫を建設するための平均コストは、1平方フィート当たり250～350ドルと推定され、1平方フィート当たり50～65ドルの標準的な倉庫よりも大幅に高いです。

主要動向

デジタル化と先端技術の採用：

デジタル化は医薬品ロジスティクス業界を変革し、医薬品の安全性、生産性、プロセス全体を強化します。医薬品ロジスティクスにおけるIoTの導入は、2025年までにオペレーションコストを25％削減し、生産性を30％向上させると予測されています。

患者直送（DTP）とラストマイル配送モデルの成長：

製薬業界では、特にCOVID-19の大流行によって加速した、患者への直接配送モデルの採用が進んでいます。

バイオ医薬品向けコールドチェーン物流の拡大：

温度に敏感なバイオ医薬品やワクチンの増加に伴い、専門的なコールドチェーン・ロジスティクスの動向が高まっています。

目次

第1章 世界の医薬品ロジスティクス市場のイントロダクション

  • 市場概要
  • 調査範囲
  • 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

  • データマイニング
  • バリデーション
  • 一次資料
  • データソース一覧

第4章 世界の医薬品ロジスティクス市場の展望

  • 概要
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • ポーターのファイブフォースモデル
  • バリューチェーン分析

第5章 世界の医薬品ロジスティクス市場：ロジスティクスタイプ別

  • 概要
  • 海上貨物
  • 航空貨物
  • 陸上輸送
  • 総合物流

第6章 世界の医薬品ロジスティクス市場：処理別

  • 概要
  • ピッキング
  • 保管
  • 検索システム
  • ハンドリングシステム

第7章 世界の医薬品ロジスティクス市場：用途別

  • 概要
  • バイオ医薬品
  • 化学医薬品
  • 専門医薬品

第8章 世界の医薬品ロジスティクス市場：地域別

  • 概要
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • その他欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • その他アジア太平洋地域
  • 世界のその他の地域
    • ラテンアメリカ
    • 中東・アフリカ

第9章 世界の医薬品ロジスティクス市場：競合情勢

  • 概要
  • 各社の市場ランキング
  • 主な発展戦略

第10章 企業プロファイル

  • Agility
  • Air Canada
  • CEVA Logistics
  • DB Schenker
  • Deutsche Post AG
  • FedEx
  • LifeConEx
  • Marken
  • United Parcel Service of America, Inc.
  • VersaCold Logistics Services

第11章 主な発展

  • 製品上市／開発
  • 合併と買収
  • 事業拡大
  • パートナーシップと提携

第12章 付録

  • 関連調査
目次
Product Code: 11782

Pharmaceutical Logistics Market Size And Forecast

Pharmaceutical Logistics Market size was valued at USD 165.94 Billion in 2024 and is projected to reach USD 429.11 Billion by 2031 , growing at a CAGR of 12.61% from 2024 to 2031. Pharmaceutical logistics is a vital part of the healthcare supply chain, encompassing the transportation, storage, and distribution of pharmaceutical products from manufacturers to end users. This specialized field ensures that pharmaceuticals including prescription medications, over-the-counter drugs, vaccines, and biologics are delivered safely, efficiently, and in compliance with strict regulatory standards. Given the sensitivity of these products, maintaining integrity, security, and regulatory compliance throughout the supply chain is paramount.

A key function of pharmaceutical logistics involves transporting and storing raw materials for drug manufacturing, such as active pharmaceutical ingredients (APIs) and excipients. Effective logistics management is essential to preserve the quality and efficacy of these materials, especially since temperature control is critical for temperature-sensitive items.

Additionally, the rising focus on personalized medicine and biologics significantly influences the future of pharmaceutical logistics. Personalized medicine tailors treatment to individual patient characteristics, necessitating the transport of small, customized quantities of medications.

Global Pharmaceutical Logistics Market Dynamics

The key market dynamics that are shaping the global pharmaceutical logistics market include:

Key Market Drivers

Growing Pharmaceutical Industry and Global Drug Sales:

The expansion of the pharmaceutical industry and increasing global drug sales are driving the demand for efficient logistics solutions. According to Verified Market Research, the Pharmaceutical Manufacturing Equipment Market market size is estimated to be valued at USD 13.95 Billion in 2023 and is expected to reach a value of USD 22.41 Billion by 2031.

Rise in Temperature-Sensitive Pharmaceuticals and Biopharmaceuticals:

The increasing production and distribution of temperature-sensitive drugs and biopharmaceuticals are driving the need for specialized cold chain logistics. According to Verified Market Research, the Biopharmaceutical Market size was valued at USD 413.83 Billion in 2023 and is expected to reach USD 674.66 Billion by 2031, with a growing CAGR of 6.30% from 2024 to 2031.

E-commerce Growth in the Pharmaceutical Sector:

The rapid growth of e-commerce in the pharmaceutical sector, accelerated by the COVID-19 pandemic, is driving demand for efficient last-mile delivery and direct-to-patient logistics solutions. In the United States, e-commerce sales of health, personal care, and beauty products grew by 32.4% in 2020, reaching USD 72.1 Billion (U.S. Census Bureau, 2021).

Key Challenges

Stringent Regulatory Requirements:

The pharmaceutical logistics providers must adhere to strict regulations to maintain product quality and safety, which can be complex and costly to implement. In the EU, approximately 200 Good Distribution Practice (GDP) inspections are conducted annually, with non-compliance rates ranging from 5% to 15%.

Temperature Excursion and Product Spoilage:

Maintaining proper temperature control throughout the supply chain is crucial but challenging, leading to potential product spoilage and financial losses. It's estimated that 25% of vaccines reach their destination degraded because of incorrect shipping procedures, with losses amounting to USD 34.1 Billion annually (World Health Organization, 2020).

High Operating Costs and Infrastructure Requirements:

The pharmaceutical logistics market faces challenges due to the high costs associated with specialized equipment, storage facilities, and transportation. The average cost to build a pharmaceutical-grade warehouse is estimated at $250-$350 per square foot, significantly higher than standard warehouses at $50-$65 per square foot.

Key Trends

Adoption of Digitalization and Advanced Technologies:

Digitalization is transforming the pharmaceutical logistics industry, enhancing drug safety, productivity, and overall processes. Implementation of IoT in pharmaceutical logistics is projected to reduce operational costs by 25% and increase productivity by 30% by 2025.

Growth of Direct-to-Patient (DTP) and Last-Mile Delivery Models:

The pharmaceutical industry is increasingly adopting direct-to-patient delivery models, particularly accelerated by the COVID-19 pandemic.

Expansion of Cold Chain Logistics for Biopharmaceuticals:

With the rise of temperature-sensitive biopharmaceuticals and vaccines, there's a growing trend towards specialized cold chain logistics.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Pharmaceutical Logistics Market Regional Analysis

Here is a more detailed regional analysis of the global pharmaceutical logistics market:

Europe

Europe substantially dominates the Global Pharmaceutical Logistics Market driven by the robust pharmaceutical industry and cross-border trade.

The significant increase in pharmaceutical trade across key European countries is a major driver for the market.

The European pharmaceutical market was valued at €277.7 billion in 2021, accounting for 23.4% of the global market (European Federation of Pharmaceutical Industries and Associations, EFPIA, 2022).

Pharmaceutical exports from the EU reached €474 billion in 2020, with Germany (€89.2 billion), Ireland (€79.1 billion), and Switzerland (€71.5 billion) being the top exporters (Eurostat, 2021).

Europe's stringent regulatory environment and high-quality standards drive the need for specialized pharmaceutical logistics services.

The European Medicines Agency (EMA) conducted 420 Good Manufacturing Practice (GMP) inspections in 2020, ensuring high-quality standards across the supply chain (EMA Annual Report, 2021).

The EU's Falsified Medicines Directive led to the implementation of a €1 billion Europe-wide medicine verification system in 2019, enhancing traceability and security in pharmaceutical logistics (European Medicines Verification Organisation, 2020).

The expansion of Europe's biopharmaceutical sector is driving demand for specialized cold chain logistics.

Asia Pacific

Asia Pacific is anticipated to witness the fastest growth in the global pharmaceutical logistics market during the forecast period owing to the rapid growth of the pharmaceutical industry in the region.

According to the China Chamber of Commerce for Import & Export of Medicines & Health Products, China's pharmaceutical exports reached USD 24.6 Billion in 2020, a year-on-year increase of 31%.

The World Health Organization reported that healthcare spending in the Asia Pacific region was expected to grow at an annual rate of 7.1% between 2020 and 2024, outpacing the global average of 5.4%.

According to the United Nations Economic and Social Commission for Asia and the Pacific (ESCAP), the number of people aged 65 and above in the region is projected to more than double from 535 million in 2019 to 1.3 billion by 2050.

Government initiatives to improve healthcare infrastructure and pharmaceutical distribution. China's "Healthy China 2030" plan aims to build a comprehensive healthcare system, with healthcare expenditure projected to reach USD 2.3 Trillion by 2030, according to the Chinese State Council.

The Indian government's "Pharma Vision 2020" initiative aims to make India a global leader in end-to-end drug manufacturing. As part of this, the government approved production-linked incentive (PLI) schemes worth ₹15,000 crore for the pharmaceutical sector in 2021.

Global Pharmaceutical Logistics Market: Segmentation Analysis

The Global Pharmaceutical Logistics Market is segmented based on Type of Logistics, Procedure, Application, And Geography.

Pharmaceutical Logistics Market, By Type of Logistics

  • Cold Chain Logistics
  • Non-Cold Logistics

Based on the Type of Logistics, the Global Pharmaceutical Logistics Market is bifurcated into Cold Chain Logistics, Non-Cold Logistics. The cold chain logistics segment dominates the global pharmaceutical logistics market. This dominance is primarily due to the rising demand for temperature-controlled products, such as COVID-19 vaccines, which require precise temperature management to preserve their efficacy. Stringent government regulations on maintaining proper temperatures for highly sensitive pharmaceuticals further boost the segment's growth.

Pharmaceutical Logistics Market, By Procedure

  • Picking
  • Storage
  • Retrieval Systems
  • Handling Systems

Based on the Procedure, the Global Pharmaceutical Logistics Market is bifurcated into Picking, Storage, Retrieval Systems, and Handling Systems. The storage segment dominates the global pharmaceutical logistics market owing to the growing demand for both generic and branded pharmaceutical products. The need for sophisticated storage facilities has surged to ensure the preservation of product efficacy post-production and to manage the seamless distribution through various channels to distributors and retailers.

Pharmaceutical Logistics Market, By Application

  • BioPharma
  • Chemical Pharma
  • Specialty Pharma

Based on the Application, the Global Pharmaceutical Logistics Market is bifurcated into BioPharma, Chemical Pharma, and Specialty Pharma. The Biopharma segment dominates the global pharmaceutical logistics market owing to its complex supply chains, which often involve multiple transportation modes and storage facilities. Maintaining precise temperature control throughout the supply chain is critical for ensuring product potency and safety. Additionally, strict regulatory compliance, including adherence to Good Distribution Practices (GDP), plays a crucial role in ensuring the safe and effective distribution of biopharma products, further reinforcing this segment's prominence in the pharmaceutical logistics market.

Pharmaceutical Logistics Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

Based on Geography, the Global Pharmaceutical Logistics Market is classified into North America, Europe, Asia Pacific, and the Rest of the World. Europe substantially dominates the global pharmaceutical logistics market driven by the robust pharmaceutical industry and cross-border trade. The significant increase in pharmaceutical trade across key European countries is a major driver for the market. The European pharmaceutical market was valued at €277.7 billion in 2021, accounting for 23.4% of the global market (European Federation of Pharmaceutical Industries and Associations, EFPIA, 2022). Pharmaceutical exports from the EU reached €474 billion in 2020, with Germany (€89.2 billion), Ireland (€79.1 billion), and Switzerland (€71.5 billion) being the top exporters (Eurostat, 2021). Europe's stringent regulatory environment and high-quality standards drive the need for specialized pharmaceutical logistics services.

Key Players

  • The "Global Pharmaceutical Logistics Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
  • Agility, Air Canada, CEVA Logistics, DB Schenker, Deutsche Post AG, FedEx, LifeConEx, Marken, United Parcel Service of America, Inc., and VersaCold Logistics Services.
  • This section offers in-depth analysis through a company overview, position analysis, the regional and industrial footprint of the company, and the ACE matrix for insightful competitive analysis. The section also provides an exhaustive analysis of the financial performances of mentioned players in the given market.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Global Pharmaceutical Logistics Market Key Developments

  • In January 2024, NX Netherlands announced the acquisition of IATA CEIV Pharma accreditation for their warehouse near Amsterdam Airport Schiphol. NX Netherlands has received IATA accreditation for pharmaceutical handling, ensuring safe and high-quality shipments.
  • In January 2024, Turkish Cargo announced the launch of breakthrough pharmaceutical logistics solutions, displaying their commitment to handling medicines and medical consignments perfectly. The company holds an IATA CEIV Pharma certificate, which ensures the safe shipment of pharmaceutical products.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL PHARMACEUTICAL LOGISTICS MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL PHARMACEUTICAL LOGISTICS MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL PHARMACEUTICAL LOGISTICS MARKET, BY TYPE OF LOGISTICS

  • 5.1 Overview
  • 5.2 Sea freight
  • 5.3 Airfreight
  • 5.4 Overland
  • 5.5 Integrated logistics

6 GLOBAL PHARMACEUTICAL LOGISTICS MARKET, BY PROCEDURE

  • 6.1 Overview
  • 6.2 Picking
  • 6.3 Storage
  • 6.4 Retrieval systems
  • 6.5 Handling systems

7 GLOBAL PHARMACEUTICAL LOGISTICS MARKET, BY APPLICATION

  • 7.1 Overview
  • 7.2 Bio Pharma
  • 7.3 Chemical Pharma
  • 7.4 Specialty Pharma

8 GLOBAL PHARMACEUTICAL LOGISTICS MARKET, BY GEOGRAPHY

  • 8.1 Overview
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 U.K.
    • 8.3.3 France
    • 8.3.4 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Rest of Asia Pacific
  • 8.5 Rest of the World
    • 8.5.1 Latin America
    • 8.5.2 Middle East and Africa

9 GLOBAL PHARMACEUTICAL LOGISTICS MARKET COMPETITIVE LANDSCAPE

  • 9.1 Overview
  • 9.2 Company Market Ranking
  • 9.3 Key Development Strategies

10 COMPANY PROFILES

  • 10.1 Agility
    • 10.1.1 Overview
    • 10.1.2 Financial Performance
    • 10.1.3 Product Outlook
    • 10.1.4 Key Developments
  • 10.2 Air Canada
    • 10.2.1 Overview
    • 10.2.2 Financial Performance
    • 10.2.3 Product Outlook
    • 10.2.4 Key Developments
  • 10.3 CEVA Logistics
    • 10.3.1 Overview
    • 10.3.2 Financial Performance
    • 10.3.3 Product Outlook
    • 10.3.4 Key Developments
  • 10.4 DB Schenker
    • 10.4.1 Overview
    • 10.4.2 Financial Performance
    • 10.4.3 Product Outlook
    • 10.4.4 Key Developments
  • 10.5 Deutsche Post AG
    • 10.5.1 Overview
    • 10.5.2 Financial Performance
    • 10.5.3 Product Outlook
    • 10.5.4 Key Developments
  • 10.6 FedEx
    • 10.6.1 Overview
    • 10.6.2 Financial Performance
    • 10.6.3 Product Outlook
    • 10.6.4 Key Developments
  • 10.7 LifeConEx
    • 10.7.1 Overview
    • 10.7.2 Financial Performance
    • 10.7.3 Product Outlook
    • 10.7.4 Key Developments
  • 10.8 Marken
    • 10.8.1 Overview
    • 10.8.2 Financial Performance
    • 10.8.3 Product Outlook
    • 10.8.4 Key Developments
  • 10.9 United Parcel Service of America, Inc.
    • 10.9.1 Overview
    • 10.9.2 Financial Performance
    • 10.9.3 Product Outlook
    • 10.9.4 Key Developments
  • 10.10 VersaCold Logistics Services
    • 10.10.1 Overview
    • 10.10.2 Financial Performance
    • 10.10.3 Product Outlook
    • 10.10.4 Key Developments

11 KEY DEVELOPMENTS

  • 11.1 Product Launches/Developments
  • 11.2 Mergers and Acquisitions
  • 11.3 Business Expansions
  • 11.4 Partnerships and Collaborations

12 Appendix

  • 12.1 Related Research